NuCana (NCNA) Stock Chart & Stock Price History → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free NCNA Stock Alerts $3.84 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media NuCana Stock Price Performance5 Day Performance+1.72%1 Month Performance-50.13%3 Month Performance-47.93%6 Month Performance-71.56%Year-To-Date Performance-48.07%1 Year Performance-82.93% Receive NCNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. NCNA Stock Chart for Friday, April, 26, 2024 NCNA Chart by TradingView NuCana Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$3.83$3.84+0.26%$4.00$3.5416,490 shs$8.03 million04/24/2024$4.00$3.83-4.25%$4.09$3.7512,017 shs$8.01 million04/23/2024$3.99$4.00+0.25%$4.13$3.8237,241 shs$8.36 million04/22/2024$3.78$3.99+5.70%$4.20$3.8150,827 shs$8.34 million04/19/2024$3.79$3.78-0.26%$3.82$3.4032,622 shs$7.90 million04/18/2024$3.97$3.79-4.53%$4.18$3.6188,508 shs$7.92 million Get the Latest News and Ratings for NCNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$3.90$3.97+1.79%$4.40$3.84108,050 shs$207.59 million04/16/2024$4.45$3.90-12.36%$5.14$3.69121,259 shs$203.93 million04/15/2024$5.60$4.45-20.50%$5.68$4.4431,893 shs$9.31 million04/12/2024$5.92$5.60-5.37%$5.98$5.3810,438 shs$11.71 million04/11/2024$5.92$5.92$5.99$5.754,879 shs$12.37 million04/10/2024$5.92$5.92-0.04%$5.93$5.639,024 shs$12.37 million04/09/2024$5.90$5.92+0.30%$6.10$5.6412,318 shs$12.38 million04/08/2024$5.82$5.90+1.42%$6.04$5.6712,574 shs$12.34 million04/05/2024$6.00$5.82-2.96%$6.10$5.6510,163 shs$12.17 million04/04/2024$6.56$6.00-8.58%$6.56$5.617,114 shs$12.54 million04/03/2024$5.75$6.56+14.14%$6.56$5.6018,072 shs$13.72 million04/02/2024$5.93$5.75-3.04%$6.13$5.6125,075 shs$12.02 million04/01/2024$6.50$5.93-8.85%$6.28$5.6820,407 shs$12.39 million03/29/2024$6.50$6.50$6.88$5.8651,815 shs$13.60 million03/28/2024$7.81$6.50-16.75%$6.88$5.8651,607 shs$13.60 million03/27/2024$7.70$7.81+1.40%$7.81$7.3119,979 shs$16.33 million03/26/2024$7.85$7.70-1.85%$7.85$7.0118,932 shs$16.11 million03/25/2024$7.60$7.85+3.19%$8.08$7.5013,090 shs$16.41 million03/22/2024$7.24$7.60+4.97%$7.86$7.2515,199 shs$15.90 million03/21/2024$8.32$7.24-12.92%$8.50$7.2341,385 shs$15.15 million03/20/2024$8.36$8.32-0.51%$8.50$8.1010,053 shs$17.40 million03/19/2024$9.18$8.36-8.88%$8.75$8.1318,339 shs$17.49 million03/18/2024$8.72$9.18+5.25%$9.50$7.6349,954 shs$19.19 million03/15/2024$9.77$8.72-10.77%$9.25$8.1684,659 shs$18.23 million03/14/2024$10.50$9.77-6.95%$10.50$9.03163,012 shs$20.44 million03/13/2024$9.77$10.50+7.47%$19.30$10.502.57 million shs$21.96 million03/12/2024$8.25$9.77+18.42%$11.00$8.00623,865 shs$20.44 million03/11/2024$8.29$8.25-0.42%$8.48$7.751,984 shs$17.26 million03/08/2024$8.25$8.29+0.42%$8.50$7.564,429 shs$17.33 million03/07/2024$8.06$8.25+2.39%$8.25$7.5111,186 shs$17.26 million03/06/2024$8.23$8.06-2.04%$8.45$7.907,450 shs$16.85 million03/05/2024$8.25$8.23-0.30%$8.73$7.882,192 shs$17.20 million03/04/2024$8.00$8.25+3.13%$9.00$7.887,190 shs$17.26 million03/01/2024$8.00$8.00$8.38$7.632,735 shs$16.73 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.02/29/2024$8.21$8.00-2.53%$8.50$7.972,767 shs$16.73 million02/28/2024$8.25$8.21-0.52%$8.75$8.001,635 shs$17.17 million02/27/2024$8.00$8.25+3.13%$9.25$7.8813,392 shs$17.26 million02/26/2024$7.75$8.00+3.23%$8.25$7.501,748 shs$16.73 million02/23/2024$8.50$7.75-8.80%$8.25$7.513,301 shs$16.21 million02/22/2024$8.25$8.50+3.00%$8.97$8.003,592 shs$17.77 million02/21/2024$8.58$8.25-3.79%$8.75$8.193,573 shs$17.26 million02/20/2024$8.77$8.58-2.22%$9.25$8.354,536 shs$17.94 million02/19/2024$8.77$8.77$9.24$7.508,388 shs$18.34 million02/16/2024$7.88$8.75+11.11%$9.24$7.507,193 shs$18.30 million02/15/2024$8.00$7.88-1.56%$8.26$7.691,514 shs$16.47 million02/14/2024$7.98$8.00+0.31%$8.25$7.417,331 shs$16.73 million02/13/2024$7.40$7.98+7.77%$8.25$7.501,381 shs$16.68 million02/12/2024$7.63$7.40-2.98%$8.50$7.3810,785 shs$15.48 million02/09/2024$7.33$7.63+4.10%$7.73$7.193,120 shs$15.95 million02/08/2024$7.32$7.33+0.07%$7.46$7.002,984 shs$15.32 million02/07/2024$7.36$7.32-0.48%$7.36$7.111,295 shs$15.31 million02/06/2024$7.20$7.36+2.15%$7.43$7.051,894 shs$15.38 million02/05/2024$7.25$7.20-0.69%$7.63$7.032,512 shs$15.06 million02/02/2024$7.98$7.25-9.09%$8.00$7.035,052 shs$15.16 million02/01/2024$7.50$7.98+6.37%$8.00$7.284,271 shs$16.68 million01/31/2024$7.50$7.50-0.03%$7.81$7.285,982 shs$15.68 million01/30/2024$7.68$7.50-2.38%$8.25$7.286,959 shs$15.69 million01/29/2024$7.38$7.68+4.17%$8.36$7.5010,746 shs$16.07 million01/26/2024$7.31$7.38+0.92%$8.49$7.2823,193 shs$15.43 million01/25/2024$7.28$7.31+0.41%$7.75$7.30647 shs$15.28 million Related Companies: Molecular Templates Stock Chart Virios Therapeutics Stock Chart Cyclerion Therapeutics Stock Chart Hepion Pharmaceuticals Stock Chart Universe Pharmaceuticals Stock Chart Lixte Biotechnology Stock Chart ASLAN Pharmaceuticals Stock Chart Biofrontera Stock Chart TFF Pharmaceuticals Stock Chart Bionomics Stock Chart Receive NCNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NCNA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.